EA006608B1 - Нафтотиазиновые позитивные аллостерические модуляторы амра-рецепторов - Google Patents

Нафтотиазиновые позитивные аллостерические модуляторы амра-рецепторов Download PDF

Info

Publication number
EA006608B1
EA006608B1 EA200301167A EA200301167A EA006608B1 EA 006608 B1 EA006608 B1 EA 006608B1 EA 200301167 A EA200301167 A EA 200301167A EA 200301167 A EA200301167 A EA 200301167A EA 006608 B1 EA006608 B1 EA 006608B1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkyl
halogen
different meanings
group
halogen atoms
Prior art date
Application number
EA200301167A
Other languages
English (en)
Russian (ru)
Other versions
EA200301167A1 (ru
Inventor
Анджело Чечи
Клаус Клиндер
Томас Вайзер
Карин Винтер
Original Assignee
Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг filed Critical Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Publication of EA200301167A1 publication Critical patent/EA200301167A1/ru
Publication of EA006608B1 publication Critical patent/EA006608B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
EA200301167A 2001-05-17 2002-05-15 Нафтотиазиновые позитивные аллостерические модуляторы амра-рецепторов EA006608B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (de) 2001-05-17 2001-05-17 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2002/005338 WO2002100411A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Publications (2)

Publication Number Publication Date
EA200301167A1 EA200301167A1 (ru) 2004-06-24
EA006608B1 true EA006608B1 (ru) 2006-02-24

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301167A EA006608B1 (ru) 2001-05-17 2002-05-15 Нафтотиазиновые позитивные аллостерические модуляторы амра-рецепторов

Country Status (26)

Country Link
EP (1) EP1404340A1 (ja)
JP (1) JP2004529980A (ja)
KR (1) KR20040007572A (ja)
CN (1) CN1533278A (ja)
AR (1) AR036332A1 (ja)
BG (1) BG108324A (ja)
BR (1) BR0209796A (ja)
CA (1) CA2449189A1 (ja)
CO (1) CO5550460A2 (ja)
CZ (1) CZ20033112A3 (ja)
DE (1) DE10123952A1 (ja)
EA (1) EA006608B1 (ja)
EC (1) ECSP034852A (ja)
EE (1) EE200300566A (ja)
HR (1) HRP20030933A2 (ja)
HU (1) HUP0401273A3 (ja)
IL (1) IL158642A0 (ja)
MX (1) MXPA03010373A (ja)
NO (1) NO20035088D0 (ja)
NZ (1) NZ530154A (ja)
PL (1) PL364053A1 (ja)
SK (1) SK14222003A3 (ja)
UY (1) UY27290A1 (ja)
WO (1) WO2002100411A1 (ja)
YU (1) YU90403A (ja)
ZA (1) ZA200308466B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039468B2 (en) * 2006-08-31 2011-10-18 The Governors Of The University Of Alberta Method of inhibition of respiratory depression using positive allosteric AMPA receptor modulators
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
US6346526B1 (en) * 1998-06-25 2002-02-12 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NO20035088L (no) 2003-11-14
DE10123952A1 (de) 2002-11-21
YU90403A (sh) 2006-05-25
HUP0401273A3 (en) 2006-11-28
AR036332A1 (es) 2004-09-01
CO5550460A2 (es) 2005-08-31
CN1533278A (zh) 2004-09-29
SK14222003A3 (sk) 2004-05-04
HUP0401273A2 (hu) 2004-10-28
ZA200308466B (en) 2004-05-24
NO20035088D0 (no) 2003-11-14
BR0209796A (pt) 2004-06-01
CA2449189A1 (en) 2002-12-19
WO2002100411A1 (en) 2002-12-19
JP2004529980A (ja) 2004-09-30
NZ530154A (en) 2005-09-30
IL158642A0 (en) 2004-05-12
PL364053A1 (en) 2004-12-13
CZ20033112A3 (en) 2004-03-17
EA200301167A1 (ru) 2004-06-24
HRP20030933A2 (en) 2004-04-30
UY27290A1 (es) 2002-12-31
ECSP034852A (es) 2003-12-24
MXPA03010373A (es) 2004-03-16
EE200300566A (et) 2004-02-16
EP1404340A1 (en) 2004-04-07
KR20040007572A (ko) 2004-01-24
BG108324A (bg) 2004-12-30

Similar Documents

Publication Publication Date Title
CA2683557C (en) Inhibitors of histone deacetylase
CA2409743C (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
DK173297B1 (da) Perhydrothiazepinderivater, fremgangsmåde til fremstilling deraf samt farmaceutisk præparat til behandling af hypertension
US6350749B1 (en) Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
US4591458A (en) 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives
HUT71494A (en) Pharmaceutical compositions containing of condensed heterocyclic amino acid derivatives
KR100818431B1 (ko) 벤조티아디아진 화합물, 이를 제조하는 방법 및 이를함유하는 약제 조성물
TW201617317A (zh) 吡啶酮衍生物
KR20100083195A (ko) 신규한 디아제니움디올레이트 유도체, 이들의 제조 방법 및 상기 화합물을 포함하는 약제 조성물
EP0711283A1 (en) Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
ES2228817T3 (es) Nuevos modulados positivos alostericos del receptor de ampa (mpara), procedimiento para su preparacion y su uso como medicamentos.
DK168010B1 (da) Tetrahydroisoquinolinforbindelser og farmaceutisk middel indeholdende en saadan forbindelse
JP2003119137A (ja) Hiv阻害剤
DK165691B (da) Tricykliske aminer afledt af 2,3,5,6,7,8-hexahydronaphtho(2,3-b)furan, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
EA006608B1 (ru) Нафтотиазиновые позитивные аллостерические модуляторы амра-рецепторов
US7026475B2 (en) Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions
EP0053017A1 (en) Amide derivatives
SK285767B6 (sk) Tiazolobenzoheterocykly, spôsob ich prípravy a liečivo, ktoré ich obsahuje
NO812790L (no) Nye diaryl-imidazol-forbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse og deres anvendelse
KR20010083109A (ko) 아미노산 유도체 및 이들을 유효 성분으로서 함유하는 약제
KR19990021835A (ko) 축합 벤조디아제피논 유도체 및 이의 의약 조성물
AU2002345759A1 (en) Naphtothiazine positive allosteric AMPA receptor modulators (PAARM)
KR900007316B1 (ko) 아민 유도체 및 이의 염, 이의 제조방법, 및 이를 함유하는 궤양 치료제
US3264295A (en) 4-amino-7-hexylamino-nu-hexyl-2-phenyl-6-pteridinethiocarboxamide
MXPA00009418A (en) PYRROLO[1,2-a]PYRAZINE sPLA2

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU